Safety and Efficacy of Exenatide as Monotherapy

Clinical trial NCT00381342 · COMPLETED

Trial details

NCT number: NCT00381342
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2006-09-01
Primary completion: 2007-09-01
Enrollment: 233

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.